Cytokine Imbalance as a Biomarker of Treatment-Resistant Schizophrenia

Cytokine Imbalance as a Biomarker of Treatment-Resistant Schizophrenia

Treatment-resistant schizophrenia (TRS) is an important and unresolved problem in biological and clinical psychiatry. Approximately 30% of cases of schizophrenia (Sch) are TRS, which may be due to the fact that some patients with TRS may suffer from pathogenetically “non-dopamine” Sch, in the develo...

Full description

Bibliographic Details
Main Authors: Natalia A. Shnayder, Aiperi K. Khasanova, Anna I. Strelnik, Mustafa Al-Zamil, Andrey P. Otmakhov, Nikolay G. Neznanov, German A. Shipulin, Marina M. Petrova, Natalia P. Garganeeva, Regina F. Nasyrova
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:International Journal of Molecular Sciences
Subjects:
cytokines
cytokine status
treatment-resistant schizophrenia
biomarker
chronic neuroinflammation
Online Access:https://www.mdpi.com/1422-0067/23/19/11324

Internet

https://www.mdpi.com/1422-0067/23/19/11324

Similar Items